A new publication outlines nanoscience and nanotechnology dedicated research expenditure in Europe over recent years, in particular via the 7th research framework programme (FP7). It highlights a selection of exemplary projects financed through FP7 that are representative of major research themes, such as nanoelectronics, nanophotonics, nanobiotechnology, nanomedicine, self-assembly, catalysts, industrial applications, energy and environment, tools for investing the nanoscale, health/safety/environment and communication/societal impact.
Nanotechnology-enabled bio-pharmaceuticals are the most innovative and highly specialized alternative medicines for curing chronic diseases. These functionally modified nanomaterials help in early detection of chronic diseases. In addition to this, they also detect the microorganisms and viruses associated with infections. In this article, the authors analyze the immense potential of nanotechnology in India's pharmaceutical and biotechnology industries.
Nanoscience and nanotechnology have emerged as important priorities not only for science but also for economic development. In this article, the authors propose an analytical framework that considers the socioeconomic effects of nanotechnology in six key areas: institutional development, knowledge flows, and network efficiency; research and education capabilities; industrial and enterprise development; regional spread; cluster and network development; and product innovation. This framework is applied to assess the early impacts of the evolving domain of nanotechnology for development, with a focus on China and its transitioning economy.
Nanobiotechnology is essentially different in many aspects from other areas of nanotechnology such as nanoelectronics or nanomaterials. It is certainly the most complex sub-area of nanotechnology. Last month, EuroNanoBio - a Support Action funded under the 7th Framework Programme of the European Union - has issued its report on a conceptual framework and a tool box to structure the European capacity in nanobiotechnology. The EuroNanoBio partners explored the definition, establishment and further development of a European scale infrastructure on nanobiotechnology and the associated realistic implementation plan. It aimed at defining not only the key features of a potential European infrastructure in nanobiotechnology, but it has also established the way it should be designed.
Europe is a key player in nanotechnology and, about on the same level as the U.S., invests hundreds of millions of dollars, or rather euros, into nanotechnology research and development projects. Whereas the U.S. National Nanotechnology Initiative (NNI) in was established in 2001 to coordinate Federal nanotechnology research and development, the European Union's slowly grinding bureaucratic mills came up with a comparable program only three years later. In May 2004, the European Commission adopted the Communication Towards a European Strategy for Nanotechnology. It seeks to bring the discussion on nanoscience and nanotechnology to an institutional level and proposes an integrated and responsible strategy for Europe. Since then, the EU has issued updates on how they are doing with two implementation reports, the last one issued just a few days ago.
Sand. Shrubs. Burst tires. More sand. The last thing you would expect as you drive along the Red Sea near Mecca is to encounter an ultramodern science city. Yet there it is. Appearing after an 80 kilometer drive from Jeddah, Saudi Arabia's second-largest city, the 36 square kilometer campus of King Abdullah University for Science and Technology (KAUST) appears like a Fata Morgana out of the desert sand. Yesterday, September 23rd, King Abdullah of Saudi Arabia officially opened the country's most modern and ambitious university near the old fishing village of Thuwal. Nanowerk was invited to attend the spectacular opening ceremony. Much more than a future elite university, the vision behind KAUST is to create the nucleus of a modern society, free from the strict religious dictates of a conservative Islamic culture, and laying the foundation for a science and technology based society of future generations.
This week's successful international nanotechnology forum Rusnanotech in Moscow has put a spotlight on Russia's ambitions to catch up with the leading nanotechnology nations. While Russia has the money, the political will, and a well educated scientific base to be a leading player, it has completely missed the boat on developing its nanoscience programs and nanotechnology infrastructure. In terms of gross domestic product, Russia ranks as the eleventh largest economy in the world. But while many smaller countries such as Australia or South Korea, not to mention all of the bigger nations, have invested steadily and broadly in all areas of nanosciences and nanotechnologies for years now, Russia has had no coordinated science policy, no industrial policy, and no commercial industrial base to develop its nanotechnology capabilities. Until last year, that is. In April 2007, the Russian president signed off on a public policy paper that ordered a multi-billion dollar program to develop a world-class Russian nanotechnology industry by 2015.
Germany, with an almost 40% share of European public funded nanoscience research, is the clear nanotechnology leader in Europe. It is also one of the leaders globally in pushing research into potential risk and safety concerns associated with nanotechnology. The Federal Ministry of Education and Research (BMBF) is the ministry responsible for federal activities in the nanotechnology sector in Germany. Within its framework of 'leading-edge innovations' the BMBF supports key areas of nanotechnologies with promising prospects (NanoMobil, NanoChem, NanoFab, NanoforLife,NanoLux). The project NanoChance aims to support small and medium-sized companies in particular. The cooperative project NanoCare currently mainly focuses on studying possible risks of engineered nanoparticles. Beyond that, the federal agencies BAuA (Federal Institute for Occupational Safety and Health), UBA (Federal Environment Agency) and BfR (Federal Institute for Risk Assessment) have developed a joint research strategy that addresses especially health and environmental risks of engineered nanoparticles. The strategy has been finalized in December 2007 and a final report has just been published.